Rockwell Medical, Inc.RMTINASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +19.12% | +11.64% | -16.59% | -37.79% | -43.75% |
| Gross Profit Growth | +183.33% | +26.52% | -0.72% | -44.99% | -63.58% |
| EBITDA Growth | +0.00% | -47.95% | +0.00% | -158.10% | -156.08% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -361.94% | -181.82% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -534.99% | -205.35% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -562.77% | -194.88% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -588.76% | -197.47% |
| Weighted Average Shares Growth | +14.65% | +14.75% | +16.30% | +12.67% | +14.18% |
| Weighted Average Shares Diluted Growth | +17.80% | +14.75% | +16.30% | +7.11% | +11.12% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +27.88% | -130.57% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +45.33% | -137.61% |
| Receivables Growth | -5.07% | -23.94% | -12.84% | -25.42% | -6.28% |
| Inventory Growth | +7.33% | -1.58% | -16.93% | -29.29% | -32.68% |
| Asset Growth | +8.51% | +13.48% | +6.38% | -0.76% | +0.70% |
| Book Value per Share Growth | +18.10% | +33.38% | +31.30% | +14.85% | +11.29% |
| Debt Growth | -4.71% | +0.71% | -9.27% | -2.57% | -7.41% |
| R&D Expense Growth | -100.00% | -99.40% | -100.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +24.91% | +27.70% | +0.73% | -4.54% | -10.39% |